An Act Regarding The Interactions Of Pharmacy Benefits Managers And So-Called 340B Entities And Reimbursements By Pharmacy Benefits Managers To Pharmacies

Maine's LD 180 prohibits health insurance carriers and pharmacy benefits managers (PBMs) from discriminating against entities participating in the federal 340B drug pricing program or their contracted pharmacies. It bans PBMs from restricting patient pharmacy choices, imposing extra fees on 340B entities, or requiring special billing for 340B claims. The bill also mandates that PBMs reimburse pharmacies for drugs at no less than the national average drug acquisition cost (plus a Medicaid-level dispensing fee) at the time of dispensing, or the wholesale acquisition cost if the national average isn't available. Additionally, PBMs cannot reimburse pharmacies less than the amount they pay themselves or their affiliates for the same drug.